New drug LY3985863 tested in healthy volunteers – no cure expected
NCT ID NCT07030127
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 25 times
Summary
This early-stage study tested the safety and side effects of a new drug called LY3985863 in 24 healthy Chinese adults. Participants received multiple doses under the skin, and researchers monitored how the drug moved through the body. Since this was a Phase 1 trial in healthy people, there was no treatment for any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking University Third Hospital
Beijing, 100191, China
Conditions
Explore the condition pages connected to this study.